These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11824167)

  • 1. [Alzheimer patients. To treat with anti-dementia drugs in spite of unanswered questions].
    Padberg F; Hampel H; Möller HJ
    MMW Fortschr Med; 2001 Dec; 143(51-52):43-5. PubMed ID: 11824167
    [No Abstract]   [Full Text] [Related]  

  • 2. [To differentiate Alzheimer's and vascular dementia? Today no longer up to date].
    Wettstein A
    MMW Fortschr Med; 2001 Dec; 143(51-52):41-2. PubMed ID: 11824166
    [No Abstract]   [Full Text] [Related]  

  • 3. [Alzheimer dementia. Comparison of the effectiveness of cholinesterase inhibitors and gingko].
    Gasser US; Gasser T
    MMW Fortschr Med; 2001 Dec; 143(51-52):40-1. PubMed ID: 11824165
    [No Abstract]   [Full Text] [Related]  

  • 4. [Alzheimer patients treated with anti-dementia drugs despite unanswered questions].
    Padberg F; Hampel H; Möller HJ
    Fortschr Med Orig; 2001 Nov; 119(3-4):141-3. PubMed ID: 11789127
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of rivastigmine in comparison to ginkgo for treating Alzheimer's dementia.
    Nasab NM; Bahrammi MA; Nikpour MR; Rahim F; Naghibis SN
    J Pak Med Assoc; 2012 Jul; 62(7):677-80. PubMed ID: 23866514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel treatment for patients with Alzheimer's disease and with vascular dementia.
    Kurz A
    Ann N Y Acad Sci; 2002 Nov; 977():476-81. PubMed ID: 12480788
    [No Abstract]   [Full Text] [Related]  

  • 7. Broad therapeutic benefits in patients with probable vascular dementia or Alzheimer's disease with cerebrovascular disease treated with galantamine.
    Lilienfeld S; Kurz A
    Ann N Y Acad Sci; 2002 Nov; 977():487-92. PubMed ID: 12480790
    [No Abstract]   [Full Text] [Related]  

  • 8. [The use of galantamine in Alzheimer's disease associated with vascular dementia (according to the study of T. Erkinjuntti group)].
    Damulin IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5):65-7. PubMed ID: 19938276
    [No Abstract]   [Full Text] [Related]  

  • 9. Conflicting results on ginkgo research.
    Le Bars P
    Forsch Komplementarmed Klass Naturheilkd; 2002 Feb; 9(1):19-20. PubMed ID: 11968151
    [No Abstract]   [Full Text] [Related]  

  • 10. Placebos in clinical trials in Alzheimer disease: an international discussion.
    Whitehouse PJ; Arizaga R; Brodaty H; Gauthier S; Graham N; Green RC; Homma A; Mangone C; Senanarong V; Xu XH
    Alzheimer Dis Assoc Disord; 1999; 13(3):121-3. PubMed ID: 10485568
    [No Abstract]   [Full Text] [Related]  

  • 11. [Preliminary assessment of ginkgo biloba (Ginkofar) in patients with dementia].
    Bidzan L; Biliekiewicz A; Turczyński J
    Psychiatr Pol; 2005; 39(3):559-66. PubMed ID: 16149765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [External validity of clinical trials for treatment of dementia with ginkgo biloba extracts].
    Bornhöft G; Maxion-Bergemann S; Matthiessen PF
    Z Gerontol Geriatr; 2008 Aug; 41(4):298-312. PubMed ID: 18327688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practice guidelines for the diagnosis and treatment of Alzheimer's disease in a managed care setting: Part II--Pharmacologic therapy. Alzheimer's Disease (AD) Managed Care Advisory Council.
    Fillit H; Cummings J
    Manag Care Interface; 2000 Jan; 13(1):51-6. PubMed ID: 10747691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study.
    Mazza M; Capuano A; Bria P; Mazza S
    Eur J Neurol; 2006 Sep; 13(9):981-5. PubMed ID: 16930364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guidelines for the treatment of dementias].
    Trabucchi M; Bianchetti A
    Recenti Prog Med; 2000 Sep; 91(9):444-9. PubMed ID: 11021167
    [No Abstract]   [Full Text] [Related]  

  • 16. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances.
    Expert Consensus Panel for Dementia
    Postgrad Med; 2005 Jan; Spec No():1-111. PubMed ID: 17203560
    [No Abstract]   [Full Text] [Related]  

  • 17. [Galantamine (reminyl) in the treatment of Alzheimer's disease and vascular dementia].
    Gavrilova SI; Zharikov GA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(12):59-65. PubMed ID: 14763262
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacologic treatment of Alzheimer's disease: an update.
    DeLaGarza VW
    Am Fam Physician; 2003 Oct; 68(7):1365-72. PubMed ID: 14567491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Smoking, drinking and mental laziness. It hastens cognitive cut-down].
    MMW Fortschr Med; 2002 Feb; 144(7):71. PubMed ID: 11887745
    [No Abstract]   [Full Text] [Related]  

  • 20. [A comparison of cholinesterase inhibitors and ginkgo extract in treatment of Alzheimer dementia].
    Schreiter Gasser U; Gasser T
    Fortschr Med Orig; 2001 Nov; 119(3-4):135-8. PubMed ID: 11789125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.